Behavior Change for Chronic Disease
We're pioneering new evidence-based digital therapeutics.
The company follows a human-centered and data-driven approach to product design, combining exceptional consumer-grade experiences with clinically-validated interventions to deliver sustainable results. ATX Therapeutics was founded in 2019 by CEO Adam Falat, and is based in Austin, Texas.
Prior to founding ATX Therapeutics, Adam led widely recognized consumer digital health product teams at Walgreens and athenahealth. At Walgreens, Adam helped build the drugstore chain’s first digital healthcare platform, which included online prescription refills used by over 3 million customers every month, and the largest retail mHealth behavior change program for managing chronic conditions with over 1 million connected devices. At athenahealth, Adam oversaw the consumer health product portfolio for a national network of 100 million patients and 160,000 providers.
Adam has received numerous recognitions during his career, including MedTech Boston’s “40 Under 40 Healthcare Innovator” award in 2015 and is a regular speaker at industry events, including SXSW Interactive, Digital Marketing in Healthcare Summit and others. Adam has been featured in several online publications, including The Guardian and Digital Telepathy. He holds a BS in Computer Science and Mathematics from the University of Illinois at Urbana-Champaign.